Bionime Corporation (4737.TW)

TWD 55.6

(-3.47%)

Eps Summary of Bionime Corporation

  • Bionime Corporation's latest annual eps in 2023 was 0.10 TWD , down -93.33% from previous year.
  • Bionime Corporation's latest quarterly eps in 2024 Q2 was -0.59 TWD , down -612.56% from previous quarter.
  • Bionime Corporation reported an annual eps of 1.50 TWD in 2022, up 2.74% from previous year.
  • Bionime Corporation reported an annual eps of 1.46 TWD in 2021, up 37.74% from previous year.
  • Bionime Corporation reported a quarterly eps of -0.08 TWD for 2024 Q1, down -143.58% from previous quarter.
  • Bionime Corporation reported a quarterly eps of -0.17 TWD for 2023 Q3, down -200.0% from previous quarter.

Annual Eps Chart of Bionime Corporation (2023 - 2009)

Historical Annual Eps of Bionime Corporation (2023 - 2009)

Year Eps Eps Growth
2023 0.10 TWD -93.33%
2022 1.50 TWD 2.74%
2021 1.46 TWD 37.74%
2020 1.06 TWD -42.7%
2019 1.85 TWD -17.04%
2018 2.23 TWD -11.51%
2017 2.52 TWD -10.64%
2016 2.82 TWD 47.64%
2015 1.91 TWD 56.56%
2014 1.22 TWD -40.49%
2013 2.05 TWD 173.33%
2012 0.75 TWD -81.3%
2011 4.01 TWD 8.67%
2010 3.69 TWD 6.96%
2009 3.45 TWD 0.0%

Peer Eps Comparison of Bionime Corporation

Name Eps Eps Difference
Nang Kuang Pharmaceutical Co., Ltd. 1.96 TWD 94.898%
Maxigen Biotech Inc. 1.86 TWD 94.624%
SciVision Biotech Inc. 2.66 TWD 96.241%
Pegavision Corporation 22.83 TWD 99.562%
Visco Vision Inc. 4.79 TWD 97.912%